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Snail reprograms glucose metabolism by repressing
phosphofructokinase PFKP allowing cancer cell
survival under metabolic stress
Nam Hee Kim1,*, Yong Hoon Cha1,*,w, Jueun Lee2,3, Seon-Hyeong Lee4, Ji Hye Yang1, Jun Seop Yun1,
Eunae Sandra Cho1, Xianglan Zhang1,5, Miso Nam2,3, Nami Kim2, Young-Su Yuk1, So Young Cha1, Yoonmi Lee1,
Joo Kyung Ryu1, Sunghyouk Park6, Jae-Ho Cheong7, Sang Won Kang8, Soo-Youl Kim4, Geum-Sook Hwang2,
Jong In Yook1 & Hyun Sil Kim1
Dynamic regulation of glucose ﬂux between aerobic glycolysis and the pentose phosphate
pathway (PPP) during epithelial–mesenchymal transition (EMT) is not well-understood. Here
we show that Snail (SNAI1), a key transcriptional repressor of EMT, regulates glucose ﬂux
toward PPP, allowing cancer cell survival under metabolic stress. Mechanistically, Snail
regulates glycolytic activity via repression of phosphofructokinase, platelet (PFKP), a major
isoform of cancer-speciﬁc phosphofructokinase-1 (PFK-1), an enzyme involving the ﬁrst
rate-limiting step of glycolysis. The suppression of PFKP switches the glucose ﬂux towards
PPP, generating NADPH with increased metabolites of oxidative PPP. Functionally, dynamic
regulation of PFKP signiﬁcantly potentiates cancer cell survival under metabolic stress and
increases metastatic capacities in vivo. Further, knockdown of PFKP rescues metabolic
reprogramming and cell death induced by loss of Snail. Thus, the Snail-PFKP axis plays an
important role in cancer cell survival via regulation of glucose ﬂux between glycolysis and
PPP.
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C
ancer cell survival under metabolic stress is a critical step
not only for solid tumour growth but also metastatic
progression1–3. While the glucose in cancer cells is mainly
metabolized through aerobic glycolysis to provide biomass,
glucose ﬂux into the pentose phosphate pathway (PPP) is an
important metabolic circuit generating NADPH (nicotinamide
adenine dinucleotide phosphate, reduced)3–5. In a resource-
limited environment such as matrix detachment or lack of
glucose supply, cancer cells suspend their anabolic glycolysis and
reprogram metabolic homeostasis, surviving mainly on mito-
chondrial oxidative phosphorylation3,6. Therefore, maintaining
an adequate level of NADPH is critical for cancer cells to survive
oxidative stress7,8. Indeed, many oncogenic signalling networks
play an important role in regulating PPP ﬂux and NADPH
homeostasis. For example, p53-induced TIGAR (identiﬁed
as fructose-2,6-bisphosphatase) reduces glycolytic activity and
promotes PPP9,10. Conversely, p53 itself inhibits G6PD, a
gatekeeper enzyme of PPP, and loss of p53 function increases
glucose ﬂux towards PPP11. LKB-AMPK activation prolongs
cancer survival under metabolic stress via suppression of
NADPH consumption4. However, the oncogenic role of
NADPH homeostasis via PPP during cancer progression has
not been widely studied.
The transcriptional repressor Snail triggers epithelial–mesen-
chymal transition (EMT), allowing cancer cells with invasive and
stemness properties1,12. Major oncogenic signalling pathways
such as canonical Wnt and p53 tumour suppressor modulate
Snail activities13–15, indicating the key role of Snail abundance
during cancer progression. Although earlier studies reinforced
phenotypic conversion and migratory potential during EMT,
recent evidence suggests that EMT of cancer cells is involved in
therapeutic resistance and cancer stemness16,17. While over-
coming metabolic stress is critical for cancer progression as well
as for therapeutic resistance, the underlying mechanism of Snail
in metabolic reprogramming is not well-understood.
The conversion of fructose-6-phosphate (F6P) to fructose-1,
6-bisphosphate (F1,6BP) catalysed by PFK-1 is the most
important control step in the mammalian glycolytic pathway,
while the oncogenic regulation of PFK-1 and its consequences are
not well known. In this study, we found that Snail functions as a
metabolic switch between aerobic glycolysis and PPP by
repressing PFKP, a cancer-speciﬁc PFK-1, allowing cancer cell
survival under metabolic stress. This study therefore provides
molecular mechanisms whereby metabolic reprogramming over-
comes oxidative stress during cancer progression.
Results
Snail supports cell survival under metabolic stress. During the
cancer progression, the cancer cell should not only proliferate in a
nourished environment, but also survive in a resource-limited
condition. Given its key function during cancer invasion and
metastasis, we investigated whether Snail abundance is required
for breast cancer cell survival under metabolic stress and
proliferation in nourished condition. In normal culture condition,
the lack of Snail slightly increased cancer cell proliferation
(Supplementary Fig. 1a) while its overexpression led to enriched
G0/G1 fraction with slowing cell growth17 (Supplementary
Fig. 1b,c). To test whether Snail abundance is required for
cancer cell survival under resource-limited conditions, we
compared cell death in a glucose-starved condition and the
clonogenic capacity of the survived cells according to the Snail
status. Contrary to in a nourished environment, knockdown of
Snail rendered cancer cells more sensitive to cell death induced by
glucose deprivation (Fig. 1a). To examine their clonogenic
capacity, starved cells were refreshed with normal culture
medium for 2 weeks until colony formation was observed.
Indeed, Snail abundance was required for clonogenic capacity of
starved cancer cells (Fig. 1b). However, knockdown of Snail after
starvation did not affect the clonogenic potential, indicating that
the protective effect of Snail is important in the early response to
glucose deprivation (Supplementary Fig. 1d). Another EMT
inducer, Slug (SNAI2), functioned similarly to Snail in terms of
cell death and clonogenic potential under metabolic stress
(Supplementary Fig. 1e). Conversely, gain of Snail potentiated
cancer cell survival and clonogenic capacity, overcoming glucose
starvation or paclitaxel treatment (Supplementary Fig. 1f–h).
Matrix detachment of carcinoma cells, which cancer cells
inevitably encounter during metastatic progression, also leads to
profound metabolic stress due to loss of glucose transport3.
Examining metabolic stress induced by anchorage loss, we found
that Snail abundance was also required for cell survival following
matrix detachment (Fig. 1c). In vivo, the matrix-detached cancer
cells must survive before tumour growth in orthotopically
implanted tissue as well as metastatic progression via
intravascular circulation. Consistent with the well-established
role of Snail in cancer progression13,14,18, lack of Snail largely
attenuated in vivo tumour initiation of orthotopically injected
MDA-MB-231 cells without extracellular matrix (Supplementary
Fig. 2a). When these cells were injected into tail vein, Snail
knockdown signiﬁcantly suppressed the metastatic potential
while its overexpression increased metastatic capacity (Fig. 1d
and Supplementary Fig. 2b). These results support that Snail
abundance is prerequisites for cancer cell survival before in vivo
tumour initiation and metastatic progression of cancer cells.
Because oxidative stress rather than ATP depletion is the
primary trigger of cell death under metabolic stress3,19,20, we next
measured reactive oxygen species (ROS) and NADPH level
following Snail knockdown to investigate the metabolic link
between Snail abundance and cell death. Loss of Snail signi-
ﬁcantly increased ROS level in breast cancer cells, especially in
glucose-deprived condition (Fig. 1e), and antioxidant treatment
reversed cell death of Snail knockdown cells under starvation
(Fig. 1f and Supplementary Fig. 2c). Because NADPH is the
major reduction power against oxidative stress, we next measured
cellular NADPH level according to Snail abundance. Indeed, loss
of Snail decreased NADPH level (Fig. 1g), while gain of Snail
function consistently increased NADPH level in a glucose-
6-phosphate dehydrogenase (G6PD)-dependent manner (Fig. 1h
and Supplementary Fig. 2d), suggesting that Snail regulates
NADPH homeostasis via PPP and thereby confers cancer cell
survival against oxidative stress.
Snail suppresses glycolytic activity in breast cancer cells. To
gain more insight into Snail function on glucose metabolism, we
performed metabolic proﬁling in terms of Snail abundance
using 1H-NMR spectroscopy. A total of 22 metabolites were
identiﬁed in MDA-MB-231 breast cancer cell extracts using
targeted metabolic proﬁling. Orthogonal partial least-squares
discriminant analysis (OPLS-DA) was applied to maximize
intergroup variance. In the OPLS-DA score plot, breast cancer
cells lacking Snail were clearly separated from those of controls
(Fig. 2a). Fourteen metabolites were found to signiﬁcantly
distinguish the loss of Snail and control group (Fig. 2a). Similar
results were observed in untargeted metabolic proﬁling of
MDA-MB-231 cells (Supplementary Fig. 3a,b). Intriguingly,
loss of Snail increased endogenous intermediate metabolites
of aerobic glycolysis and lactate, a hallmark end product of
glycolysis (Fig. 2b,c). Amino acid biosynthesis, including of
serine-driven one carbon units such as glycine, was increased by
loss of Snail compared with control. The inverse relationship
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between Snail abundance and lactate production was further
conﬁrmed by independent experiments on Snail loss or gain
(Fig. 2d and Supplementary Fig. 3c). Consistently, we success-
fully traced the metabolic fate of 13C-glucose to 13C-lactate
following knockdown of Snail in MDA-MB-231 cells (Fig. 2e
and Supplementary Fig. 3d). These results indicate that Snail
leads to metabolic reprogramming via repression of glycolytic
ﬂux in breast cancer cells.
Snail regulates phosphofructokinase PFKP expression. To
elucidate the mechanistic link between Snail and metabolic
reprogramming, we postulated that transcriptional repressor
Snail directly regulates the rate-limiting step of aerobic glycolysis.
Previous microarray studies have shown that many genes
involved in glycolysis were repressed by Snail21,22. In terms of
Snail function on glycolytic activity, we focused on PFK-1, which
catalyses the ﬁrst committed step of glycolysis, irreversibly
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Figure 1 | Snail potentiates cancer cell survival under starvation via overcoming oxidative stress. (a) Cells were cultured in absence of glucose, and cell
death was quantitated by trypan blue exclusion assay (left). Immunoblot analysis shows endogenous Snail protein abundance (right). In total, 20 mg of
cell lysates were used to detect endogenous Snail, and loading controls were validated from reprobing the same blot. Antibody validations for
immunoblot analysis are provided in Supplementary Fig. 10. (b) Clonogenic survival assay of cancer cells following glucose starvation as described in
‘Methods’ section (left). Colonies of more than 50 cells were counted after crystal violet staining (right). (c) Cell death of breast cancer cells expressing
control-shRNA or Snail-shRNA cultured 24 h after plating in attached or detached (poly-HEMA-coated) plates. (d) Lung metastasis by tail vein
xenograft of MDA-MB-231-D3H2LN cells. In total, 5 105 cells either of control (shControl, n¼6) or of knockdown of Snail (shSnail, n¼ 7) were
inoculated intravenously into immunodeﬁcient mice. The number of lung metastatic nodules at day 28 was counted under microscopic examination
(left). Statistical signiﬁcance was determined by Mann–Whitney test. Whole-ﬁeld images of representative lungs that showed median value for each
group (right). Arrows indicate metastatic tumour foci in mouse lung. Scale bar, 1 mm. (e) The cancer cells expressing control-shRNA or Snail-shRNA
were incubated in the presence of glucose (Glcþ ) or absence (Glc ) for 2 h. The ROS levels are expressed as the relative change in the mean DCF
values relative to the glucose-treated control shRNA. (f) Antioxidant BHA (100 mM) treatment rescued cell death induced by glucose deprivation of
Snail knock-downed cells. (g) The effect of Snail knockdown on NADPþ/NADPH ratio in cancer cells. (h) Inducible Snail overexpression increased
NADPH production in a G6PD-dependent manner. Snail was induced by treatment of doxycycline (Dox) for 48 h in combination with control or G6PD
siRNA. NADPþ/NADPH ratio (left) and protein abundance (right) were determined. In total, 5 mg of cell lysates were used to detect overexpressed
ﬂag-tagged Snail and endogenous G6PD, and loading controls were validated from reprobing the same blot. Data are means±s.d. from n¼ 3 (a–c) or
n¼ 5 (e–h) independent experiments. Statistical signiﬁcances compared with control were denoted as *Po0.05; **Po0.01 by a two-tailed Student’s
t-test. Unprocessed original scans of blots are shown in Supplementary Fig. 12.
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converting F6P to F1,6P. Because PFK-1 functions as the
gatekeeper of glycolytic ﬂux, its expression and activity are
tightly regulated10. Similar to pyruvate kinase23, three isoforms of
PFK-1 exist from mammalian: PFKL and PFKM, expressed in
liver and muscle, respectively, and PFKP, mainly expressed in
platelet and cancer24,25. When we re-evaluated the abundance of
PFK-1 isoforms, the PFKP was preferentially detected in human
cancer cells while non-tumourigenic MCF-10A cells mainly
expressed PFKL (Fig. 3a and Supplementary Fig. 4a, validation of
cell line in Supplementary Fig. 11). Thus, PFKP isoform is a
major PFK-1 controlling the ﬁrst rate-limiting step of aerobic
glycolysis in human cancer cells. Importantly, the transcripts,
protein abundance and kinase activity of PFKP were consistently
increased by loss of Snail (Fig. 3b and Supplementary Fig. 4b),
while they were suppressed by Snail overexpression (Supple-
mentary Fig. 4c,d). Because posttranslational modiﬁcation of
PFK-1 results in inhibition of the kinase activity26, we further
determined whether Snail abundance modulates O-glycosylation
or phosphorylation of PFKP. However, post-translational modi-
ﬁcations were not affected by Snail (Supplementary Fig. 4e),
indicating that Snail represses PFKP mainly on a transcriptional
level, similar to E-cadherin and BRCA-1 (refs 27,28). Indeed, as
the PFKP proximal promoter harbours multiple Snail-binding
canonical E-boxes (CACCTG), we could clone the promoter
region of PFKP into the reporter vector with mutations of the
putative Snail binding sites individually or in combination
(Fig. 3c). The PFKP reporter activity increased when we
silenced Snail, whereas the speciﬁc mutation of predicted
binding sites attenuated the ability of Snail to suppress reporter
activity (Fig. 3d). We next used chromatin immunoprecipitation
(ChIP) assay to determine whether Snail comprises a repressor
complex in PFKP promoter. As expected, a DNA fragment
containing the E-boxes can be ampliﬁed from the genomic DNA
immunoprecipitated samples from antibody of endogenous Snail
in an E-box dependent manner (Fig. 3e and Supplementary
Fig. 4f).
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Figure 2 | Snail suppresses aerobic glycolysis in cancer cells. (a,b) Metabolic proﬁle analysis following knockdown of Snail in MDA-MB-231 cells. OPLS-
DA score plot (R2X¼0.888, R2Y¼0.992, Q2¼0.945) (a) and loading column plot (b) of metabolite concentrations through targeted proﬁling derived
from 1H NMR spectra of MDA-MB-231 cell extracts expressing control shRNA (shControl) and Snail shRNA (shSnail). (c) A diagram and quantiﬁcation of
the changes in intracellular metabolites in MDA-MB-231 cells. *,** and *** indicate Po0.05, Po0.01 and Po0.001 calculated from the Mann–Whitney
U test. NADþ , nicotinamide adenine dinucleotide (oxidized form); O-PC, O-phosphocholine. The x and y axis represent experimental groups (blue bars,
shControl; red bars, shSnail) and metabolite concentration (mM), respectively. (d) Quantiﬁcation of intracellular lactate following knockdown of Snail in
MCF-7 and MDA-MB-231 cells. ** Po0.01 compared with the control by Student’s t-test. (e) The relative abundance of 13C-lactate from MDA-MB-231 cell
extracts was quantiﬁed from 1D 1H{13C} HSQC peak intensity. Data are means±s.d. from n¼ 5 independent experiments. ** Po0.01 compared with the
control by Student’s t-test.
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PFKP is a key ﬂux controller between glycolysis and PPP. We
next examined the regulatory role of PFKP in metabolic repro-
gramming and cancer cell survival. An OPLS-DA score plot of
targeted metabolic proﬁles from 1H NMR spectra of MDA-
MB-231 cells revealed remarkably different metabolic patterns by
inducible knock-down of PFKP (Fig. 4a). Due to the ﬁrst rate-
limiting role of PFK-1 on glycolysis, knockdown of PFKP
signiﬁcantly suppressed lactate production and amino acids bio-
synthesis from phosphoenolpyruvate and pyruvate (Fig. 4b–d).
Similar results were observed through untargeted metabolic
proﬁling following inducible knockdown of PFKP in MDA-MB-
231 cells (Supplementary Fig. 5a,b). Tracing with 13C-glucose
further showed suppression of 13C-lactate according to the PFKP
knockdown (Fig. 4e and Supplementary Fig. 5c). Consistent with
previous ﬁndings that oxidative phosphorylation was indepen-
dent on glycolytic ﬂux29, the mitochondrial oxygen consumption
rate in either the presence or absence of oligomycin was slightly
decreased by suppression of PFKP (Fig. 4f and Supplementary
Fig. 5d). These results demonstrate that (1) PFKP is a gate-
controller of glycolytic ﬂux in cancer cells, and (2) PFKP func-
tions inversely to Snail on glycolytic activity.
Recent ﬁndings suggest that inhibition of glycolysis redirects
glucose ﬂux towards the PPP19,26,30. To examine the role of PFKP
in regulating glucose ﬂux between glycolysis and PPP, we next
determined NADPH and ROS levels in breast cancer cells
according to the PFKP abundance. Loss of PFKP increased
NADPH level in a G6PD-dependent manner (Fig. 5a and
Supplementary Fig. 6a,b). Because the serine-driven one carbon
pathway in glycolysis can provide a large fraction of NADPH31,
we next performed mass spectrometry analysis to quantitatively
measure endogenous metabolites of oxidative PPP. Indeed,
suppression of PFKP increased the amount of ribulose-
5-phosphate (R5P; Fig. 5b), supporting that PFKP regulates
glucose ﬂux into PPP in cancer cells. Since PFK-1 deﬁciency leads
to glycogen storage disease (known as Tarui’s disease) via
conversion of glucose-6-phosphate to glucose-1-phosphate32, we
next examined glycogen amounts to determine whether PFKP
silencing leads glucose reﬂux to glycogenesis in cancer cells.
However, the glycogen level was not increased by PFKP silencing
regardless of glucose concentration in breast cancer cells (Supple-
mentary Fig. 6c).
Examining the functional relevance of metabolic reprogram-
ming by suppression of PFKP, we found that suppression of
glycolytic activity coupled with increased PPP ﬂux led the rever-
sible G0-G1 arrest similar to cancer dormancy (Supplementary
Fig. 6d,e)17,33. Importantly, suppression of PFKP signiﬁcantly
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Figure 3 | PFKP is a major isoform of PFK-1 in cancer cells and a target of Snail repressor. (a) PFK-1 immunoblotting of cell lysates from various human
cancer cells. In total, 5mg of each cell lysate for PFKP and 30 mg of cell lysate for PFKM or PFKL were subjected to immunoblot analysis. The ﬁlms were
developed at the same exposures to compare relative protein abundance of PFK-1 isoforms, and protein loading of each blot was validated with Ponceau
stain. The PFK-1 antibody validation using positive control of platelet, muscle and liver tissue are shown in Supplementary Fig. 10c. Cell lines used in this
study was authenticated by short tandem repeat proﬁling as shown Supplementary Fig. 11. (b) Relative transcript (left) and protein (right) abundance of
PFKP following knockdown of Snail (shSnail) in breast cancer cells. A total of 20mg and 5 mg of cell lysates were used to detect endogenous Snail and PFKP,
respectively. Representative blots are shown from at least two independent experiments (a,b). (c) Schematic diagram showing positions of potential Snail-
binding canonical E-boxes on the PFKP proximal promoter reporter constructs. Arrow, transcription start site; empty boxes denote E-box mutant. (d) Fold
increase of reporter activities in combination with wild type or mutated PFKP promoter following Snail shRNA compared with each control shRNA in breast
cancer cells. *Po0.05; **Po0.01 compared with the control. (e) Chip-enriched DNA was determined by RT-PCR using speciﬁc primers complementary to
the promoter regions containing E-box of PFKP (upper) and E-cadherin (lower). Statistical signiﬁcances (b,d) compared with control were denoted as
*Po0.05; **Po0.01 by a two-tailed Student’s t-test. Unprocessed original scans of blots are shown in Supplementary Fig. 12.
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potentiated cancer cell survival and clonogenic capacity under
metabolic stress (Fig. 5c,d), and RNAi-resistant PFKP expression
vector could successfully attenuate the survival and clonogenic
potential of cancer cells induced by shRNA-mediated PFKP
knockdown (Supplementary Fig. 6f,g). Because anti-oxidative
capacity is closely related to chemotherapeutic resistance of
cancer cells34, we next examined the role of PFKP suppression on
cancer cell survival against paclitaxel treatment. Intriguingly,
inducible knockdown of PFKP signiﬁcantly increased clonogenic
capacity of breast cancer cells against paclitaxel treatment
(Fig. 5e), suggesting that suppression of PFKP followed by
redirection of glucose ﬂux towards PPP plays an important role in
slowing cell growth coupled with therapeutic resistance of cancer
cells.
The maintenance of PPP ﬂux is responsible for cancer cell
survival against oxidative stress induced by matrix detach-
ment3,19,26. To form metastatic colonization as well as to gain
tumour-initiation capability, matrix-detached carcinoma cells
must survive before proliferative outgrowth in the foreign
microenvironment1,18. Therefore, our observations suggest a
possibility that metabolic reprogramming towards PPP via
suppression of PFKP can increase the tumour-initiating and
metastatic potential of cancer cells by overcoming metabolic
stress. To examine whether metabolic reprogramming regulated
by PFKP plays a role in tumour- and metastatic-initiation18,35, we
designed an in vivo experiment controlling PFKP abundance with
an inducible system at the initial period of tumour implantation
or systemic circulation (Fig. 5f). Interestingly, transient loss of
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Figure 4 | PFKP is the gate controller of glucose ﬂux into glycolysis. (a,b) Metabolic proﬁle of NMR spectra following inducible knockdown of PFKP in
MDA-MB-231 cells. OPLS-DA score plot (R2X¼0.893, R2Y¼0.985, Q2¼0.977) (a) and loading column plot (b) of metabolite concentrations through
targeted proﬁling derived from 1H NMR spectra of MDA-MB-231 cell extracts treated with control shRNA (Dox ) and PFKP shRNA (Doxþ ).
(c) A diagram and quantiﬁcation of the changes in intracellular metabolites following inducible knockdown of PFKP in MDA-MB-231 cells. *,** and ***
indicates Po0.05, Po0.01 and Po0.001 calculated from Mann–Whitney U test. NADþ , nicotinamide adenine dinucleotide (oxidized form); O-PC,
O-phosphocholine. The x and y axis represent experimental groups (yellow bars, shControl; green bars, shPFKP) and metabolite concentration (mM),
respectively. (d) Relative lactate level following doxycycline-inducible PFKP shRNA (Doxþ ) in breast cancer cells (left). Immunoblot analysis
shows PFKP protein abundance in two independent sets of shRNA against PFKP (right). In total, 5 mg of cell lysates were used to detect endogenous
PFKP, and loading controls were validated from reprobing the same blot. The image is representative of two independent experiments. (e) The relative
abundance of 13C-lactate from the 13C-glucose tracer experiment in MDA-MB-231 cells. (f) Mitochondrial OCR (delta OCR pre- and post- rotenone)
in Tet-inducible PFKP shRNA. Data are means±s.d. from n¼ 3 (d) or n¼ 5 (e,f) independent experiments. Statistical signiﬁcances compared with
control are denoted as *Po0.05; **Po0.01 by a two-tailed Student’s t-test. Experiment (d) is representative and was replicated from at least two
independent experiments.
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PFKP during an initial period in quantities that generated
suboptimal engraftment signiﬁcantly enhanced in vivo tumour
initiation (Supplementary Fig. 6h). Further, the dynamic
suppression of PFKP increased the lung metastatic potential of
MDA-MB-231 cells (Fig. 5g). These results reveal that dynamic
repression of PFKP plays an important role in potentiating cancer
cell survival before in vivo tumour initiation and metastatic
progression.
During the EMT program, cancer cells acquired metastatic
potential accompanied with suppression of epithelial genes and
increased abundance of mesenchymal genes. To assess whether
PFKP constitutes a mediator of Snail-mediated phenotypic
conversion, we next examined transcript abundance of represen-
tative EMT phenotypic genes according to the PFKP status.
Interestingly, PFKP abundance did not affect the transcript
abundance of EMT genes which were regulated by Snail in breast
cancer cells (Supplementary Fig. 7), indicating that the Snail-
PFKP axis mainly involves glucose metabolism independent of
phenotypic conversion. Canonical Wnt signalling is a well-known
upstream regulator of Snail controlling cancer progression, while
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Figure 5 | Repression of PFKP induces glucose reﬂux towards PPP thus providing survival advantage to breast cancer cells. (a) PFKP controls NADPH
level via G6PD-dependent manner. The NADPþ/NADPH ratio (left) and protein abundance (right) of indicated cells were measured following inducible
knockdown of PFKP (Doxþ ) in combination with control siRNA or G6PD siRNA. In total, 5 mg of cell lysates were used to detect PFKP and G6PD, and
loading controls were validated from reprobing the same blot. (b) Quantitative mass spectrometry analysis of PPP metabolite following inducible
knockdown of PFKP. HPLC-ESI-MS/MS peak areas of ribulose-5-phosphate/ribose-5-phosphate of cells expressing PFKP shRNA (Doxþ ) compared with
control (Dox ). (c,d) Cell death quantiﬁcation (c) and clonogenic capacity (d) after glucose starvation following inducible knockdown of PFKP (Doxþ )
compared with control (Dox ). (e) Clonogenic survival of breast cancer cells against paclitaxel treatment as indicated by concentration. The PFKP was
knocked-down with doxycycline (Doxþ ) for 48 h before paclitaxel treatment (left). The colony number was determined by stereomicroscopic examination
under high power ﬁeld (right). Data are means±s.d. from n¼ 3 (a) or n¼ 5 (c–e) independent experiments. Statistical signiﬁcances compared with control
are denoted as *Po0.05; **Po0.01 by a two-tailed Student’s t-test. (f) An experimental design to determine functional relevance of dynamic regulation of
PFKP. Inducible PFKP shRNA expressing cells were either untreated (Dox ) or pretreated with doxycycline (Doxþ ) in vitro 48h before inoculation.
Recipient mice received either PBS (Dox ) or doxycycline via intraperitoneal delivery at day 0, 2, 4. (g) Lung metastasis by tail vein xenograft of MDA-
MB-231-D3H2LN cells. 1 105 cells either of control (Dox , n¼6) or of transient knockdown of PFKP (Doxþ , n¼ 5) were inoculated intravenously into
immunodeﬁcient mice. The number of lung metastatic nodules was counted under microscopic examination (left). Statistical signiﬁcance was determined
by Mann–Whitney test. Whole-ﬁeld images of representative lungs that showed median metastatic value for each group (right). Arrows indicate metastatic
tumour foci in mouse lung. Scale bar, 1mm.
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metabolic reprogramming by Wnt is not well-known13,36,37.
Thus, our observations raised the question of whether the
canonical Wnt pathway is involved in metabolic reprogramming
in a Snail-dependent manner. We found that induction of
Wnt1 increased NADPH production, cancer cell survival and
clonogenic capacity under metabolic stress while knockdown of
Snail rescued Wnt-induced metabolic reprogramming (Fig. 6).
These results provide novel observations that the Snail plays a
role, at least in part, in metabolic reprogramming regulated by
canonical Wnt pathway.
Roles of PFKP during metabolic reprogramming by Snail.
Finally, given the ability of Snail to potentiate cell survival with an
inverse metabolic rewiring to PFKP, we sought to determine
whether PFKP constitutes a key element in the reprogramming of
glucose metabolism by Snail. To conﬁrm the Snail-PFKP axis, we
designed an experimental system in which modulation of PFKP
could rescue metabolic reprogramming and cancer cell survival
regulated by Snail. Indeed, the lactate and NADPH production
following loss of Snail were largely relieved by inducible knock-
down of PFKP (Fig. 7a,b and Supplementary Fig. 8a). The
regulatory axis was also functional on cell death and clonogenic
capability under glucose starvation or induced by matrix
detachment (Fig. 7c–e and Supplementary Fig. 8b). Further,
dynamic suppression of PFKP restored the in vivo tumour-
initiating and metastatic potential of cancer cells having a Snail-
knockdown background (Fig. 6f and Supplementary Fig. 8c).
Overexpression of PFKP consistently rescued Snail-mediated
metabolic reprograming by means of increased glycolytic activity,
decreasing NADPH level and cancer cell survival (Supplementary
Fig. 9a,b). Further, the overexpression of PFKP attenuated
tumour-initiation and metastatic potential in vivo (Supple-
mentary Fig. 9c,d). Hence, PFKP plays a key role in regulating
Snail-mediated metabolic reprogramming in breast cancer cells
(Fig. 6g).
Discussion
In aerobic glycolysis, the reactions catalysed by hexokinase, PFK-
1 and pyruvate kinase (PK) are accompanied by high free-energy
change and are virtually irreversible38. Therefore metabolic
reprogramming of cancer cells mainly regulates these irrever-
sible enzymatic steps for efﬁcient proliferation or survival
depending on microenvironment resources. Indeed, a speciﬁc
isoform of PK is tightly regulated by receptor tyrosine kinase and
ROS level19,23. As a transcriptional repressor, Snail can regulate
many genes involved in glucose metabolism, such as glucose
phosphate isomerase and aldolases21, suggesting that Snail
participates in complex metabolic reprogramming in cancer
cells. This study has aimed to prove the hypothesis that the
Snail-PFKP axis plays an important regulatory role in aerobic
glycolysis. First, lactate production by Snail-gain or –loss
consistently supports the notion that Snail suppresses aerobic
glycolysis. Second, global proﬁling of endogenous metabolites as
well as tracing analysis with 13C-glucose showed Snail and PFKP
to be inversely correlated. Third, knock-down of PFKP largely
rescued metabolic reprogramming and cell death induced by
Snail-loss, supporting that Snail regulates glycolytic activity via
gatekeeper PFKP. In this light, recent ﬁndings regarding loss of
fructose-1,6-bisphosphatase 1 (FBP1) in triple negative breast
cancer and renal cell carcinoma are of considerable interest24,25,
because FBP1 is involved in gluconeogenesis by means of reverse
reaction catalysed by PFK-1. Considering glucose produced from
gluconeogenesis is mainly consumed by the brain under
starvation and glycolysis38, suppression of FBP1 in cancer cells
can also provide survival advantage under metabolic stress, such
as hypoxic or glucose-starved condition24. Thus, bidirectional
suppression of PFKP and FBP1 by Snail allow tight glucose ﬂux
control towards PPP and efﬁcient glycolysis, providing survival
advantage and enabling a critical trade-off between cell proli-
feration and survival during cancer progression23,24,39.
We observed that the PFKP isoform prevails over PFKM or
PFKL in human cancer cells25,40. Interestingly, compared with
other isoforms, PFKP is less sensitive to feedback inhibition
by ATP and more sensitive to activation by fructose
2,6-bisphosphate (F2,6BP), the most potent allosteric activator
of PFK-1 (refs 41,42). While we showed that Snail suppressed
PFKP activity at the transcriptional level, it should be noted that
oncogenic regulations of PFK-1 kinase activity have been
reported. In response to hypoxia, posttranslational O-linked
b-N-acetylglucosamine (O-GlcNAc) modiﬁcation of PFK-1
resulted in inhibition of the kinase activity and redirected
glucose ﬂux towards PPP26. Intriguingly, O-GlcNAc modiﬁ-
cation also stabilizes Snail protein by inhibition of GSK-3-
mediated phosphorylation and subsequent degradation43. These
indicate that O-GlcNAc modiﬁcation on PFK-1 and Snail
synergistically controls glucose ﬂux towards PPP. In turn,
uridine diphospho-N-acetylglucosamine (UDP-GlcNAc) biosyn-
thesized from glucose, glutamine, acetyl-co-A and ATP may serve
as a regulator of glucose ﬂux via posttranslational modiﬁcation of
Snail and PFK-1 (ref. 26). The p53 tumour-suppressor induced
TIGAR lowered F2,6BP in cells, resulting in inhibition of PFK-1
and glycolytic activity9. Conversely, loss of p53 function in
human cancer provides active PFK-1 by increased glucose uptake
and F2,6BP level, allowing high glycolytic activity for biomass
synthesis9,11.
The reducing power of NADPH is critically required not only
for macromolecule synthesis during cancer cell proliferation, but
0
100
200
300
400
500
MCF-7 MDA-MB-231
Cl
on
og
en
ic 
ca
pa
cit
y 
(%
)
Wnt1(–)/shControl
Wnt1(+)/shControl
Wnt1(+)/shSnail
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
MCF-7 MDA-MB-231
N
AD
P+
/N
AD
PH
Wnt1(–)/shControl
Wnt1(+)/shControl
Wnt1(+)/shSnail
0
20
40
60
MCF-7 MDA-MB-231
Ce
ll d
ea
th
 (%
)
Wnt1(–)/shControl
Wnt1(+)/shControl
Wnt1(+)/shSnail
0
0.2
0.4
0.6
0.8
1
1.2
1.4
MCF-7 MDA-MB-231
R
el
at
iv
e 
la
ct
at
e 
le
ve
l
Wnt1(–)/shControl
Wnt1(+)/shControl
Wnt1(+)/shSnail – +
– +
+ – +
– +
+
shSnail
Tubulin
PFKP
HA (Wnt1)
- 95
- 35
- 55
- 40
**
** **
**
**
** ****
****
**
** ** **
** **
Wnt1-HA
Snail
MCF-7 MDA-MB-231
a b
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also to resist oxidative stress under starved condition3–5. Indeed,
the ROS detoxiﬁcation capability is more important than anabolic
biomass production in advanced cancer3,44. Interestingly, p53
suppresses PPP and NADPH production via binding to G6PD,
and p53 mutants lack the G6PD-inhibitory function resulting in
enhanced PPP ﬂux in human cancer11. In this study, we observed
that the canonical Wnt pathway is also involved in NADPH
homeostasis via Snail-mediated PFKP suppression. However, it
should be noted that nuclear factor-like 2, a transcription factor
regulating NADPH homeostasis, is also regulated by GSK-3
and the b-TrCP degradation complex, similar to Snail and
beta-catenin36,37,45,46.
While transcriptional repressor Snail has long been noted as a
critical phenotypic EMT inducer27, recent ﬁndings suggest that
EMT comprises a wide range of cancer cell biologic behaviour,
such as cancer stemness and therapeutic resistance16. Intere-
stingly, the PFKP abundance was independent to phenotypic
changes of EMT markers. Therefore, our and recent observations
indicate that regulations of glycolysis and gluconeogenesis
implicate a wide range of cellular functions of Snail repressor
beyond phenotypic conversion during the cancer progression24.
Our ﬁndings may also provide a mechanistic link accounting for
previous observations that cancer stem cells or cancer cells
undergoing EMT are resistant to cell death accompanied by
increased detoxiﬁcation of ROS and slow cell proliferation17,44,47.
Thus, Snail-PFKP axis regulating glucose ﬂux into PPP and
NADPH homeostasis, especially in a resource-limited catabolic
environment, constitutes an important metabolic programming
during the solid cancer progression4,8,11.
Methods
Cell culture conditions and western blotting. MDA-MB-231 cells (a gift from
G. Mills) and HCC-1954 cells were cultured in a RPMI1640 with 5% FBS
(HiClone). MCF-10A cells (a gift from M. Wicha) were cultured in DMEM/F12
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denoted as *Po0.05; **Po0.01 by a two-tailed Student’s t-test. (f) Lung metastasis by tail vein xenograft of Snail-expressing MDA-MB-231-D3H2LN cells. In
total, 5 105 cells either of control (Dox , n¼6) or of transient knockdown of PFKP (Doxþ , n¼ 8 for shPFKP and n¼6 for shPFKP-2) were inoculated
intravenously into immunodeﬁcient mice. Inducible PFKP shRNA expressing cells were either untreated (Dox ) or treated with doxycycline (Doxþ ) as
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determined by Mann–Whitney test. Whole-ﬁeld images of representative lungs that showed median metastatic value for each group (middle and right).
Arrows indicate metastatic tumour foci in mouse lung. Scale bar, 1mm. (g) A schematic diagram depicting a potential mechanism by which the Snail/PFKP
axis regulates glucose ﬂux towards PPP in cancer cells. Red arrows denote irreversible rate-limiting steps in glycolysis. G-6-P, glucose-6-phosphate; F-6-P,
fructose-6-phosphate; F-1,6-P, fructose-1,6-bisphosphate; PEP, phosphoenolpyruvate; 6-PG, 6-phosphogluconate; R-5-P, ribulose-5-phosphate; HK, hexokinase;
GPI, glucose phosphate isomerase; G6PD, glucose-6-phosphate dehydrogenase; PKM2, pyruvate kinase M2 isoform.
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with 5% horse serum, 20 mgml 1 EGF, 0.5 mgml 1 hydrocortisone, 0.1 mgml 1
cholera toxin, 5 mgml 1 insulin and 100 IUml 1 penicillin/streptomycin.
Metastatic MDA-MB-231-D3H2LN cells (Caliper LifeSciences) were maintained
with Eagle’s MEM containing 10% FBS. All other cells were cultured in DMEM
(Invitrogen) containing 10% FBS, 2mM L-glutamine and 100 IUml 1 penicillin/
streptomycin. Mycoplasma infection was tested regularly with a PCR-based kit
(MP0040, Sigma). 293T cells were used for lentivirus production. The transfection
was performed by Lipofectamine 2000 according to the manufacturer’s protocol
(Invitrogen). For the western blot analyses, protein extracts were prepared in
Triton X-100 lysis buffer14. Antibodies against Snail (3,895 s, Cell Signalling, mouse
monoclonal, L70G2, 1:2,000), Slug (9585S, Cell Signalling, rabbit, C19G7, 1:1,000),
PFKP (sc130227, Santa Cruz, rabbit polyclonal, C-23, 1:1,000), PFKM
(HPA002117, Sigma, rabbit polyclonal, 1:1,000), PFKL (sc130226, Santa Cruz,
rabbit polyclonal, C-22, 1:1,000), G6PD (sc373887, Santa Cruz, mouse monoclonal,
G-6, 1:1,000), Flag (F-3156, Sigma, mouse monoclonal, 1:5,000), HA (12177700,
Roche, mouse monoclonal, 12CA5, 1:5,000), O-GlcNAc (MMS-248R, Covance,
mouse monoclonal, CTD110.6, 1:1,000) and tubulin (LF-PA0146, AbFrontier,
rabbit polyclonal, 1:5,000) were obtained from the commercial vendors. The phos-
tag reagents were purchased from Wako Chemicals, and gels containing phos-tag
were prepared according to the manufacturer’s instructions. DCF was purchased
from Molecular Probe and all other chemicals were purchased from Sigma-Aldrich
unless otherwise indicated.
Plasmids and stable cell lines using lentivirus. Tetracyclin-inducible Snail
expression vector was generated with the pTRIPZ lentiviral system (Open Bio-
systems) by replacing RFP with Flag-tagged Snail13. Flag-tagged PFKP expression
vector was generated from cDNA library (Addgene 23869). Ha-tagged Wnt1
retroviral expression vector was described previously37. Lentivirus-mediated
(pLL3.7-dsRed) Snail knockdown was described previously48. The Tet-pLKO-puro
vector (#21915 obtained from Addgene) was used for inducible shRNA
knockdown. The target sequences of shRNA were 50-ggacgagaggagatttcaaga for
shPFKP, 50-gcaacgtagctgtcatcaacg for human shPFKP-2, 50-gatgcacatccgaagccac for
shSnail, 50-ccactcagatgtcaagaagta for shSnail-2, 50-gtctgtcccagagcttattgg for
shG6PD-2 and 50-cctaaggttaagtcgccctcg for shControl-2. A pLKO-Slug-shRNA
vector (#10903) was obtained from Addgene. Double strand siRNA oligo for
transient knockdown of G6PD were purchased from Santa Cruz. For RNAi
resistant ﬂag-tagged PFKP expression vector, the target site of shPFKP was
mutated without affecting amino acid sequences (50-ggatgaacgccgtttccagga,
mutation underlined).
Cell death and clonogenic survival capacity assay. For the glucose starvation
experiments, 5 103 cells were plated into 6-well plates with normal culture
medium a day before starvation. The cells were washed with PBS and cultured in
glucose-free DMEM containing 10% dialysed FBS (Invitrogen). The MDA-MB-231
cells and MCF-7 cells were starved for 48 and 72 h, respectively. Cell death induced
by glucose starvation was measured by trypan blue exclusion assay. Separately,
clonogenic survival was performed by exposing cells to glucose starved condition
followed by further observation in normal culture medium for 14 days49. After
crystal violet (0.5% w/v) staining, colonies of more than 50 cells were counted
under stereomicroscope. The results of clonogenic assay are expressed as the ratios
of the number of survival colonies compared with control. For clonogenic survival
against paclitaxel treatment, 5 103 cells were plated into 6-well plates with
normal culture medium 48 h before paclitaxel treatment in absence or presence of
doxycycline for inducible expression of Snail or PFKP shRNA. The cells were then
cultured in paclitaxel-containing culture medium for 48 h followed by refreshment
of normal culture medium for an additional 10–14 days to determine clonogenic
survival. The number of colonies in 5 randomly chosen ﬁelds was determined
under high power stereomicroscope. For ECM detachment assays, the cells were
plated on poly-HEMA (2-hydroxyethyl methacrylate)-coated plates with complete
culture medium for 24 h, and cell death then measured by trypan exclusion. The
results of cell death by glucose starvation and matrix detachment are expressed as
the ratio of the number of dead cells to the number of total cells counted. Cell
growth was analysed by MTT (3-(4,5-dimethylthiazol-yl)-2,5-diphenyltrazolium
bromide) reduction and absorbance of formazan crystals dissolved in dimethyl
sulfoxide was measured at 595 nm. Cell number was counted with an EVE
automatic counter (NanoEnTek).
Quantitative PCR. Total RNA was isolated using TRIzol reagent (Invitrogen)
following the manufacturer’s protocol. The SuperScript III synthesis kit
(Invitrogen) was used to generate cDNA. Real-time quantitative PCR analysis for
PFK-1 isoform transcripts was performed with an ABI-7300 instrument under
standard conditions and SBGR mix (n¼ 3). The expression of DCt value from each
sample was calculated by normalizing with GAPDH. Primer speciﬁcity and PCR
process were veriﬁed by dissociation curve after PCR reaction. Sequence infor-
mation for qPCR primers are summarized in Supplementary Information.
Metabolic analysis and PFK kinase assay. The intracellular levels of NADPH
and total NADP (NADPH and NADPþ ) were measured using previously reported
enzymatic cycling methods4. In brief, cells (5 105) were lysed in 200 ml of
extraction buffer (20mM nicotinamide, 20mM NaHCO3, 100mM Na2CO3) and
supernatant was incubated at 60 C for 30min. Next, 160 ml of NADP-cycling
buffer (100mM Tris-HCl pH 8.0, 0.5mM thiazolyl blue, 2mM phenazine
ethosulfate, 5mM EDTA, 1.3U of G6PD) was added to a 96-well plate containing
20 ml of the cell lysate. After incubation in the dark at 30 C, 20 ml of 10mM
glucose-6-phophate was added to the mixture, and the change in absorbance at
570 nm was measured every 30 s for 4min at 30 C. The concentration of NADPþ
was calculated by subtracting (NADPH) from (total NADP). The intracellular level
of H2O2 was measured with DCF (Molecular Probes). Brieﬂy, cells (1 105) were
treated with DCF for 30min. The cells were then washed with PBS and collected as
single-cell suspensions. Fluorescence was detected by ﬂow cytometry. Lactate level
PFK-1 kinase activities were measured using colorimetric assay kit according
to the manufacturer’s protocol (Biovision). The results are expressed as the ratios
of experiment to control from three independent experiments. The oxygen
consumption rates (OCRs) were measured using the Seahorse XF-24 instrument
(Seahorse Bioscience) under standard conditions and after the addition of 1 mM
oligomycin, 0.25 mM FCCP and 0.5 mM rotenone/antimycin A. Real-time
measurements of the OCR in pmol per minute per mg per protein in adjusted base
medium (L-glutamine 2.05mM, D-glucose 2 gl 1) were plotted over time before
the addition of rotenone/antimycin A, and after addition of rotenone/antimycin A
to speciﬁcally measure non-mitochondrial respiration. The difference in OCR
between initial non-drug treated and after addition of rotenone/antimycin A
reﬂects the basal oxygen consumption by mitochondria. The OCR measurements
were normalized with protein abundance of plated cells through BCA assay at a
wavelength of 562 nm.
1H NMR and mass spectrometric analysis of metabolites. After the culture
medium was removed from the culture dish, MDA-MB-231 cells (2 107) were
quickly washed with ice-cold PBS. Cells were then detached from the culture dish
by treatment of trypsin and quenched with HPLC grade 100% cold methanol
( 20 C) followed by freeze-drying. Intracellular metabolites were extracted with a
solvent composed of methanol, chloroform and water (4/4/2.85, v/v/v)50. The
aqueous phase containing water soluble metabolites was collected and freeze-dried.
For NMR analysis, cell extract was resuspended in 300ml of 100mM sodium
phosphate buffered deuterium oxide (pH 7.0) containing 0.1mM 3-(trimethylsilyl)
propionic-2,2,3,3-d4 acid (TSP-d4) and transferred into Shigemi NMR tubes
matched with D2O (Shigemi). 1H NMR spectra were acquired on a VNMRS
600-MHz NMR using a triple-resonance HCN salt-tolerant cold probe (Agilent
Technologies) and an Ascend 800-MHz NMR using a triple-resonance 5mm
cryogenic probe (Bruker BioSpin AG). All NMR spectra were phased and baseline
corrected using Chenomx NMR suite version 6.1 (Chenomx). The spectra were
then normalized to the total spectral area and aligned using the correlation
optimized warping (COW) method. Multivariate analysis was performed using
SIMCA-P version 12.0 (Umetrics). Metabolite chemical shifts were assigned using
Chenomx NMR suite version 6.1 (Chenomx Inc.) and literature51–53, and their
identities were conﬁrmed based on total correlation spectroscopy (2D 1H–1H
TOCSY) and spiking experiments. Quantiﬁcation was achieved using the 600MHz
library from Chenomx NMR Suite version 6.1 which uses the concentration of a
known reference signal (TSP-d4) to determine the concentration of individual
compounds. Mann–Whitney tests were performed to determine signiﬁcant
differences among group means for non-parametric statistical hypothesis test using
GraphPad PRISM version 5.0 (GraphPad Software). The differences were tested on
a 95% probability level (Po0.05). For the [U-13C6]-glucose tracer experiment,
MDA-MB-231 cells were cultured in the RPMI1640 medium containing 0.2%
13C6-labelled glucose for 24 h. Polar metabolites were extracted from cells with a
solvent composed of methanol, distilled water and chloroform. The extracts were
subjected 1D 1H{13C} HSQC NMR analysis54. For mass spectrometric analysis of
PPP metabolites R-5-P (ribose-5-phosphate/ribulose-5-phosphate), the cell pellets
(1 107 cells, MDA-MB-231) were resuspended with 200 ml of M.A.D. buffer
(methanol:acetonitrile:DW¼ 5:3:2, v/v/v) and brieﬂy vortexed. The mixtures
were then centrifuged at 28,000 g for 20min at 4 C to remove the pellets.
Approximately 180 ml of supernatant was centrifuged once again and 170 ml of
supernatant was then evaporated to dryness by SpeedVac. The dried samples were
solubilized in 20 ml of M.A.D. buffer and 2 ml injected into HPLC-ESI-MS/MS.
HPLC-MS/MS analysis was performed with an Agilent 1100 Series HPLC system
coupled to a Hybrid Q-Trap API 2000 mass spectrometer (AB SCIEX) with
electrospray ionization (ESI) in the negative mode. R-5-P was detected with MRM
(multiple reaction monitoring)55.
PFKP promoter assay and chromatin immunoprecipitation. To analyse the
PFKP promoter activity, the promoter region ( 539Bþ 36 from the transcrip-
tion starting site) was ampliﬁed from genomic DNA of MCF-7 cells and subcloned
into pGL3 basic vector (Promega). E-box sequence 50-CACCTG was mutated to
50-AACCTA. To examine the PFKP promoter activity, the breast cancer cells were
transfected with 100 ng of reporter vectors and 5 ng of pSV-Renilla expression
vector. Luciferase and Renilla activities were measured using the dual-luciferase
reporter system kit (Promega), and the luciferase activity was normalized with
Renilla activity. The results are expressed as the averages of the ratios of the
reporter activities from triplicate experiments. For ChIP analysis, cells were cross-
linked with 1% (v/v) formaldehyde at room temperature, suspended in a ChIP lysis
buffer containing 10mM HEPES [pH 7.9], 0.5% NP-40, 1.5mM MgCl2,
10mM KCl, 0.5mM DTT and protease inhibitor cocktail on ice56. Following
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centrifugation, the pellets were resuspended in buffer containing 20mM HEPES
[pH 7.9], 25% glycerol, 0.5% NP-40, 0.42M NaCl, 1.5mM MgCl2, 0.2mM EDTA
and protease inhibitors followed by extraction of nuclear proteins. Nuclear pellets
were resuspended in IP buffer (1% Triton X-100, 2mM EDTA, 20mM Tris-HCl
[pH 8.0], 150mM NaCl and protease inhibitors) and sonicated to break chromatin
into fragments with an average length of 0.5–1 kb. The supernatants were
incubated overnight with anti-Snail antibody or corresponding normal IgG. After
incubation with protein G-agarose beads (Invitrogen) for 2 h at 4 C, the beads
were extensively washed with lysis buffer. Bound DNA-protein complexes were
eluted following an overnight incubation at 65 C in TE buffer. To amplify the
PFKP and E-cadherin promoter fragments, the following primers were used for
RT-PCR analysis: E-cadherin, forward 50-ataacccacctagaccctagcaac, reverse
50-ctcacaggtgctttgcagttc; PFKP, forward 50-ctagagcccccaaccagagt, reverse
50-gtgtgggcaggagcatctac. Separately, the cells were transfected with PFKP reporter
construct (1 mg) of wild type (wt) or of E-boxes mutant (3xMut) followed by ChIP
analysis to examine speciﬁc binding of Snail onto E-box. Following pull-down with
Snail antibody as described above, the fold enrichment of transfected PFKP
promoter fragment of wt or 3xMut reporter was detected using quantitative PCR
with primers for exogenous pGL3 reporter (RVprimer3, 50-ctagcaaaataggctgtccc)
and PFKP promoter (50-actctggttgggggctctag). The results were normalized relative
to input activities and presented as mean±s.d. from three independent experiments.
Xenograft and lung metastasis assay. All animal experiments were performed in
accordance with the Institutional Animal Care and Use Committee of the Yonsei
University and approved by the Animal Care Committee of the Yonsei University
College of Dentistry and National Cancer Center Research Institute. Female
athymic nude mice (6-weeks old) were used for orthotopic xenograft assays into
the mammary fat pads and lung metastasis assay. For loss of function study with
Snail knockdown or PFKP overexpression, MDA-MB-231 cells of control or
experimental cells were harvested with trypsin treatment and injected orthotopi-
cally into the mammary fat pads (1 106 per 0.1ml of PBS) without extracellular
matrix. For gain of function with transient PFKP knockdown, the MDA-MB-231
cells and metastatic clone expressing Tet-inducible PFKP shRNA were treated with
control or doxycycline (5 mgml 1) for 48 h before injection, and further intra-
peritoneal administration of doxycycline three times (at day 0, 2, 4) after tumour
inoculation at a dose of 10mg kg 1. A xenograft assay for transient knockdown of
PFKP was performed with a suboptimal number (1 105 per 0.1ml of PBS) of
MDA-MB-231 cells. The tumour initiating capacity was measured twice a week
using a digital caliper, and the tumour volume was calculated with the equation V
(in mm3)¼ (a b2)/2, where a is the longest and b is the shortest diameter. Cell
proliferation and death from parafﬁn-embedded tumour tissue were measured with
immunohistochemical staining using anti-Ki-67 (MA5-14520, SP6, rabbit poly-
clonal, 1:100, Invitrogen) and active Caspase-3 (559565, C92-605, rabbit poly-
clonal, 1:100, BD Bioscience) antibodies, respectively. After staining with Ki-67,
digital images were taken under the light microscope ( 200). Stained cells in those
images were adjusted for colour threshold and Ki-67 positive proliferating cells
were counted with the ImageJ program. For lung metastasis assays, MDA-MB-231-
luc-D3H2LN cells were injected into lateral tail vein, detailed experimental
conditions described in each ﬁgure legend. Lung colonization was monitored and
quantiﬁed using pathological examination at day 28. Mice were killed and perfused
with 4% paraformaldehyde and lungs were extracted for parafﬁn-embedding.
Parafﬁn-embedding sections were stained with routine haematoxylin and eosin
and the number of lung metastatic nodules was counted under microscopic
examination.
Statistical analysis and reproducibility. All statistical analysis of cell death,
clonogenic, NADPH and lactate was performed with two-tailed Student’s t-tests;
data are expressed as means and s.d. The **denote Po0.01, *Po0.05. Statistical
signiﬁcance of animal experiments and metabolomic analysis was determined
using the Mann–Whitney test. No statistical method was used to predetermine
sample size.
Data availability. Metabolomics NMR data that support the ﬁndings of this study
have been deposited in MetaboLights (http://www.ebi.ac.uk/metabolights) under
the accession codes MTBLS387. All other data are available within the manuscript
or from the corresponding authors upon reasonable request.
The authors declare that all the data supporting the ﬁndings of this study are
available within the article and its Supplementary information ﬁles and from the
corresponding author upon reasonable request.
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